1AD
Click for more information
0.00% 1.8¢ adalta limited

Ann: SYNThesis BioVentures MoU for cellular immunotherapies, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. JabraD
    15,516 Posts.
    lightbulb Created with Sketch. 1283
    clock Created with Sketch.
    08/04/24
    09:35
    Post #: 73233420
    I guess its alright, not always been a fan of the MoU

    See how market reacts
    1AD Price at posting: 2.9¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
right-arrow Created with Sketch.
NEWS HotCopper Highlights: Your most watched and most discussed stocks this week
right-arrow Created with Sketch.
NEWS Update on the ASX' most anticipated drill campaign
right-arrow Created with Sketch.
NEWS Trump is President Again: What Does This Mean for Crypto?
right-arrow Created with Sketch.
RMX Red Mountain Mining (ASX:RMX) announces Bonanza Grade Gold Results at Flicka Lake
right-arrow Created with Sketch.
EQN Equinox Resources reports outstanding naturally occurring antimony grade at Alturas Project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
(20min delay)
Last
1.8¢ 		Change
0.000(0.00%) 		Mkt cap ! $11.36M
Open High Low Value Volume
1.8¢ 1.8¢ 1.8¢ $3.848K 213.8K

Buyers (Bids)

No. Vol. Price($)
1 433202 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
1.9¢ 543699 3
View Market Depth
Last trade - 09.59am 08/11/2024 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.